Webinar: Precise genome editing with A.s. Cas12a (Cpf1) Ultra: a mutant protein with the reliability of S.p. Cas9

Learn all about the CRISPR-Cas12a (Cpf1) enzyme and its improved performance, higher efficiency, and increased target range.

DATE: Wednesday, June 19th, 2019

TIME: Sorry, this event is over.

Add a valuable new CRISPR tool to your arsenal.

Dr Christopher Vakulskas, IDT Senior Staff Scientist, and Bernice Thommandru, IDT Research Scientist, will highlight the improved performance, higher efficiency, and increased target range of the Alt-R A.s. Cas12a (Cpf1) Ultra enzyme developed by their team.

CRISPR-Cas12a (Cpf1) is an RNA-guided DNA endonuclease that recognizes TTTV (V = A/G/C) PAM sites, thereby permitting editing in organisms with AT-rich genomes. It has been widely reported that the wild-type A.s. Cas12a enzyme lacks the potency and site-to-site reliability of S.p. Cas9 when used to edit the human genome. Despite this shortcoming, A.s. Cas12a is an attractive option for genome editing due to its AT-rich PAM sequence, high fidelity, and its native reliance on a single short RNA guide.

In this webinar, IDT staff scientist Dr Chris Vakulskas will talk about the development of a mutant protein, A.s. Cas12a (Cpf1) Ultra, which has dramatically improved cleavage activity that rivals S.p. Cas9 without altering its PAM specificity. The A.s. Cas12a (Cpf1) Ultra protein also demonstrates low-temperature cleavage activity superior to that of L.b. Cas12a, making it a universal Cas12a solution for genome editing in both animal and plant species. Finally, IDT research scientist Bernice Thommandru will describe optimal HDR methods and reagents for maximizing HDR rates when using either A.s. Cas12a (Cpf1) Ultra or S.p. Cas9.